Zobrazeno 1 - 10
of 252
pro vyhledávání: '"Jung Yong, Hong"'
Autor:
Choong-kun Lee, Changhoon Yoo, Jung Yong Hong, Se Jun Park, Jin Won Kim, David Wai Meng Tai, Hyeyeong Kim, Krittiya Korphaisarn, Suebpong Tanasanvimon, San-Chi Chen, Ju Won Kim, Ilhwan Kim, Moonho Kim, Joan Choo, Sang-Bo Oh, Ching-Tso Chen, Woo Kyun Bae, Hongsik Kim, Seok Jae Huh, Chia-Jui Yen, Sejung Park, Dong Ki Lee, Landon Long Chan, Beodeul Kang, Minsu Kang, Raghav Sundar, Hye Jin Choi, Stephen Lam Chan, Hong Jae Chon, Myung-Ah Lee
Publikováno v:
Liver Cancer, Pp 1-15 (2024)
Introduction: Atezolizumab plus bevacizumab is a commonly used first-line regimen for advanced hepatocellular carcinoma (HCC) treatment owing to its superior outcomes compared to sorafenib. However, optimal subsequent treatment options for patients w
Externí odkaz:
https://doaj.org/article/48cd992dee674cbb8551afa29b350663
Autor:
Bo Hyun Kim, Hee Chul Park, Tae Hyun Kim, Young-Hwan Koh, Jung Yong Hong, Yuri Cho, Dong Hyun Sinn, Boram Park, Joong-Won Park
Publikováno v:
JHEP Reports, Vol 6, Iss 4, Pp 100991- (2024)
Background and Aims: Nivolumab was the first immune checkpoint inhibitor approved for hepatocellular carcinoma (HCC). External beam radiation therapy (EBRT) is locally effective and may enhance the effectiveness of immunotherapy. This study investiga
Externí odkaz:
https://doaj.org/article/8f31677ff257430f8b7f01273edc0299
Autor:
Kangpyo Kim, Hee Chul Park, Jeong Il Yu, Joon Oh Park, Jung Yong Hong, Kyu Taek Lee, Kwang Hyuck Lee, Jong Kyun Lee, Joo Kyung Park, Jin Seok Heo, Sang Hyun Shin, Ji Hye Min, Kyunga Kim, In Woong Han
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 45, Iss , Pp 100732- (2024)
Background: To evaluate the efficacy and optimal timing of local treatment in patients with borderline resectable (BR) or locally advanced pancreatic cancer (LAPC) treated with upfront FOLFIRINOX. Method: Between 2015 and 2020, 258 patients with panc
Externí odkaz:
https://doaj.org/article/b61aeb37243a40a3a98e1d0a3242d69d
Autor:
Nalee Kim, Jeong Il Yu, Hee Chul Park, Jung Yong Hong, Ho Yeong Lim, Myung Ji Goh, Yong-Han Paik
Publikováno v:
Journal of Liver Cancer, Vol 23, Iss 2, Pp 350-361 (2023)
Background/Aim Patients with large (>5 cm) hepatocellular carcinoma (HCC) have limited treatment options, thus necessitating the identification of prognostic factors and the development of predictive tools. This study aimed to identify prognostic fac
Externí odkaz:
https://doaj.org/article/bbe0547ad2184a9a89d905555482bd36
Autor:
Byeong Seok Sohn, Jeongeun Kim, Miso Kim, Jung Yong Hong, Jieun Lee, Song Ee Park, Hyojeong Kim, Hyo Jin Lee, Eun Joo Kang, Soon Il Lee, In Hee Lee, Seok Jae Huh, Jeongmin Jo, Ho Young Kim
Publikováno v:
Cancer Medicine, Vol 12, Iss 14, Pp 15159-15175 (2023)
Abstract Background Extramammary Paget's disease (EMPD) is rare. There are no standard treatments due to its rarity and few clinical trials. Methods The objective of this multicenter study was to investigate treatment outcomes of Korean patients with
Externí odkaz:
https://doaj.org/article/df826c92a4414bae9cbf04d45015e3ab
Autor:
Ji Eun Kim, Hyemin Kim, Binnari Kim, Hye Gyo Chung, Hwe Hoon Chung, Kyoung Mee Kim, Seong Hyun Kim, Woo Kyoung Jeong, Young Kon Kim, Ji Hye Min, Jin Seok Heo, In Woong Han, Sang Hyun Shin, Hee Chul Park, Jeong Il Yu, Joon Oh Park, Seung Tae Kim, Jung Yong Hong, Se‐Hoon Lee, Kwang Hyuck Lee, Jong Kyun Lee, Kyu Taek Lee, Kee‐Taek Jang, Joo Kyung Park
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 7748-7761 (2023)
Abstract Pancreaticobiliary tract cancer has a poor prognosis with unmet needs in a new target treatment. Some studies have reported that an enhancement of T‐cell immunity is associated with a good prognosis. The aim of this study is to investigate
Externí odkaz:
https://doaj.org/article/9071de54d0284ff989a250770586c1f5
Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
Autor:
Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi
Publikováno v:
Clinical and Molecular Hepatology, Vol 29, Iss 2, Pp 197-205 (2023)
Hepatocellular carcinoma (HCC) is a major cause of death in many countries, including South Korea. To provide useful and sensible advice for clinical management of patients with HCC, the Korean Liver Cancer Association and National Cancer Center Kore
Externí odkaz:
https://doaj.org/article/d0d1bb195e404b0e82689fc0906e540d
Autor:
Sun Young Jeong, Jung Yong Hong, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Jae Yeon Jang, Youngkyung Jeon, Seung Tae Kim
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 16 (2023)
Background: With a 15% incidence, KRAS is one of the most common mutations in biliary tract cancer (BTC) and is a poor prognostic factor. Immune checkpoint inhibitors (ICIs) as salvage therapy have modest activity in BTC. Objectives: There are limite
Externí odkaz:
https://doaj.org/article/0bb07600025f4925b23ab1ee1ce2d3fc
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract The association between non-alcoholic fatty liver disease (NAFLD) and the risk of pancreatic cancer in the general population remains unclear. This nationwide cohort study included 8,120,674 adults who underwent a national health screening i
Externí odkaz:
https://doaj.org/article/55ec8ad4f9ec49ce978985aa00c9c579
Publikováno v:
Liver Cancer (2023)
Introduction: The association between smoking cessation and intrahepatic and extrahepatic cholangiocarcinoma (iCCA and eCCA) risk is unclear. Furthermore, the association in individuals with preexisting risk factors is unknown. We aimed to investigat
Externí odkaz:
https://doaj.org/article/aca5582ad2c049f58b8b6bd46c5afd40